Khaled Musallam, MD, PhD
Thursday, January 29, 2026, 8:00-9:00 am (San Francisco)

In this session:
- General overview
- Lessons from beta-thalassemia that are still open questions in alpha thalassemia
- Disease burden in the Arabian Peninsula
–
The International Alpha Thalassemia Consortium brings together an interdisciplinary group of clinicians and scientists from around the world to focus expertise in hematology, maternal-fetal medicine, genetics, fetal therapy, and neonatology on alpha thalassemia major (ATM).
We gather to share advances, challenges, and best practices regarding clinical care for prenatal, pediatric, and adult patients diagnosed with ATM. Each session lasts one hour, including a 30-minute presentation, followed by moderated discussion.